Millions of people take upwards of five medications a day, but testing the side effects of such combinations is impractical. Now, Stanford computer scientists have figured out how to predict side effects using artificial intelligence.
Last month alone, 23 percent of Americans took two or more prescription drugs, according to one CDC estimate. Furthermore, 39 percent over age 65 take five or more, a number that’s increased three-fold in the last several decades. And if that isn’t surprising enough, try this one: in many cases, doctors have no idea what side effects might arise from adding another drug to a patient’s personal pharmacy.
The problem is that with so many drugs currently on the U.S. pharmaceutical market, “it’s practically impossible to test a new drug in combination with all other drugs, because just for one drug that would be five thousand new experiments,” said Marinka Zitnik, a postdoctoral fellow in computer science. With some new drug combinations, she said, “truly we don’t know what will happen.”
But computer science may be able to help. In a paper presented July 10 at the 2018 meeting of the International Society for Computational Biology in Chicago. Zitnik and colleagues Monica Agrawal, a master’s student, and Jure Leskovec, an associate professor of computer science, describe an artificial intelligence system for predicting, not simply tracking, potential side effects from drug combinations. That system, called Decagon, could help doctors make better decisions about which drugs to prescribe and help researchers find better combinations of drugs to treat complex diseases.
Too many combinations
Once it’s available to doctors in a more user-friendly form, Decagon’s predictions would be an improvement over what’s available now, which essentially comes down to chance – a patient takes one drug, starts taking another and then develops a headache or worse. There are about 1,000 known side effects and 5,000 drugs on the market, making for nearly 125 billion possible side effects between all possible pairs of drugs. Most of these have never been prescribed together, let alone systematically studied.
Zitnik, Agrawal and Leskovec realized they could get around that problem by studying how drugs affect the underlying cellular machinery in the body. They composed a massive network describing how the more than 19,000 proteins in our bodies interact with each other and how different drugs affect these proteins. Using more than 4 million known associations between drugs and side effects, the team then designed a method to identify patterns in how side effects arise based on how drugs target different proteins.
To do that, the team turned to deep learning, a kind of artificial intelligence modeled after the brain. In essence, deep learning looks at complex data and extracts from them abstract, sometimes counterintuitive patterns in the data. In this case, the researchers designed their system to infer patterns about drug interaction side effects and predict previously unseen consequences from taking two drugs together.
Just because Decagon found a pattern doesn’t necessarily make it real, so the group looked to see if its predictions came true In many cases, they did. For example, there was no indication in the team’s data that the combination of atorvastatin, a cholesterol drug, and amlopidine, a blood pressure medication, could lead to muscle inflammation. Yet Decagon predicted that it would, and it was right. Although it did not appear in the original data, a case report from 2017 suggested the drug combination had led to a dangerous kind of muscle inflammation.
That example was born out in other cases as well. When they searched the medical literature for evidence of 10 side effects predicted by Decagon but not in their original data, the team members found that five out of the ten have recently been confirmed, lending further credence to Decagon’s predictions.
“It was surprising that protein interaction networks reveal so much about drug side effects,” said Leskovec, who is a member of Stanford Bio-X, Stanford Neurosciences Institute and the Chan Zuckerberg Biohub.
Right now, Decagon only considers side effects associated with pairs of drugs. In the future, the team members hope to extend their results to include more complex regimens, Leskovec said. They also hope to create a more user-friendly tool to give doctors guidance on whether it’s a good idea to prescribe a particular drug to a particular patient and to help researchers developing drug regimens for complex diseases with fewer side effects.
“Today, drug side effects are discovered essentially by accident,” Leskovec said, “and our approach has the potential to lead to more effective and safer health care.”
The Latest on: Drug side effects
via Google News
The Latest on: Drug side effects
- Lack of digital ECGs slows roll-out of anti-TB drug on December 31, 2018 at 7:59 am
According to latest estimates drawn by the MoHFW, the official said that while there have been side-effects in few patients, 80 per cent of the patients have reportedly been cured because of the drug. ... […]
- ‘Miracle drug’ worth horror side effects? on December 29, 2018 at 8:00 pm
"Pen, what's wrong with your skin?" I was 21 years old. I had just come home from five glorious days of camping, sun, friends and no mirrors or smartphones to speak of. Now my dad was staring at me li... […]
- FDA warns consumers about e-cigarette liquids with erectile dysfunction drugs on December 29, 2018 at 7:06 pm
“These FDA-approved prescription drugs are not approved for inclusion ... and anyone who experiences side effects should report them to the FDA’s MedWatch Adverse Event Reporting program. […]
- Confronting the Side Effects of a Common Anti-Cancer Treatment on December 27, 2018 at 8:30 am
The current drug therapy is linked to such complaints as hot flashes, memory lapses, anxiety and depression, side effects so bothersome that some patients discontinue the life-saving treatment, the re... […]
- Depression may be a side effect of some common drugs, including ones for acid reflux and hypertension on December 24, 2018 at 11:00 am
Consumer Reports has no financial relationship with any advertisers on this site. All medications have the potential to cause unwanted side effects, and depression is among them. One-third of American... […]
- New Study Now Reveals IBS Drugs May Produce Some Side Effects on December 24, 2018 at 1:44 am
A new systematic review and meta-analysis involving 26 trials was published in The American Journal of Medicine. The lead author was Dr. Mark Pimentel, director of Cedars-Sinai's Gastrointestinal ... […]
- Repurposed Drug May Help Preserve Hearing of Children Taking Cisplatin on December 23, 2018 at 9:12 am
AN ANTIOXIDANT APPROVED FOR use as an antidote to cyanide poisoning may also prevent hearing loss, a potential side effect of the chemotherapy drug cisplatin, in children who take the anticancer drug. ... […]
- Global Impetigo Treatment Market 2019-2023: Low Cost of Treatment / Side Effects of Drugs / Competitive Landscape - ResearchAndMarkets.com on December 19, 2018 at 8:40 am
DUBLIN--(BUSINESS WIRE)--Dec 19, 2018--The "Global Impetigo Treatment Market 2019-2023" report has been added to ResearchAndMarkets.com's offering. The impetigo treatment market will register a CAGR o... […]
- Global Thrombosis Drugs Market Outlook to 2023; Driven by the Growing Awareness of Cardiac Care - ResearchAndMarkets.com on December 18, 2018 at 7:55 am
Blood thinners have high efficacy. However, the side effects associated with the use of these drugs to treat thrombosis are high. With the presence of a considerable number of companies, this market a... […]
via Bing News